fda semaglutide warning news october 2025 Says to Drop Suicide From GLP-1 Drug Labels Semaglutide shortage ends as FDA

Proper organization of your supplies is key to a smooth injection process

Zepbound FDA Approval and Its Black Box Warning Zepbounds FDA approval came on November 8, 2023

Diabetes Care 39, 625631 (2016)

While clinical trials document taste alterations in a subset of users, most people experience either no change or a quick return to baseline taste function

Precision Peptide Co at least attempts to differentiate by making testing data accessible

Some of the most serious long-term effects include gastroparesis (stomach paralysis), bowel obstruction, gallbladder disease, vision loss linked to anterior ischemic optic neuropathy, and even potential links to thyroid and pancreatic cancer